Efficacy of Intensity Modulated Radiation Therapy After Surgery in Early Stage of Esophageal Carcinoma;
NCT01745107 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 240
Last updated 2019-01-31
Summary
The purpose of this study is to determine the efficacy of preventive intensity modulated radiation therapy after surgery in stage T2-3N0M0 disease of thoracic esophageal squamous cell carcinoma(UICC 7th edition) and to identify the subgroup benefiting from the treatment.
Conditions
- Esophageal Neoplasm
- Esophageal Cancer TNM Staging Primary Tumor (T) T2
- Esophageal Cancer TNM Staging Primary Tumor (T) T3
- Esophageal Cancer TNM Staging Regional Lymph Nodes (N) N0
- Esophageal Cancer TNM Staging Distal Metastasis (M) M0
Interventions
- RADIATION
-
Prophylactic postoperative radiation therapy
Prescription dose of 95%planning target volume(PTV) 50.4Gy/1.8Gy/28fractions for supraclavicular region and 95%PTV 56Gy/2Gy/28fractions for mediastinum which is delivered in 2 months after surgery.
Sponsors & Collaborators
-
Sichuan Cancer Hospital and Research Institute
collaborator OTHER -
Tianjin Medical University Cancer Institute and Hospital
collaborator OTHER -
Chinese Academy of Medical Sciences
lead OTHER
Principal Investigators
-
Zefen Xiao, MD · The Department of Radiation Oncology ,Cancer Institute & Hospital,Chinese Academy of Medical Science
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 40 Years
- Max Age
- 72 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-10-31
- Primary Completion
- 2018-12-31
- Completion
- 2021-12-31
Countries
- China
Study Locations
More Related Trials
-
Comparable Study of Different Radiation Dose in Esophageal Carcinoma
NCT01937208 ·Status: UNKNOWN ·Phase: PHASE3
-
Hypofractionated vs. Conventional Chemoradiotherapy After Induction Chemo-immunotherapy for Unresectable Esophageal Squamous Cell Carcinoma
NCT06912074 ·Status: RECRUITING ·Phase: PHASE2
-
Postoperative Radiotherapy in Thoracic Esophageal Squamous Cell Carcinoma With Neoadjuvant Chemoradiotherapy
NCT03734952 ·Status: RECRUITING ·Phase: NA
-
S-1 IMRT Versus S-1 and Cisplatin Concurrent IMRT in Inoperable Esophageal Squamous Cell Carcinoma
NCT02913066 ·Status: UNKNOWN ·Phase: PHASE2
-
Concurrent Chemoradiotherapy for Stage IVB Esophageal Squamous Cell Carcinoma(EC-CRT-003)
NCT05512520 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Compare Efficacy and Safety of DRT VS CRT Plus Surgery in Patients Who Achieved CCR for Esophageal Cancer
NCT03708042 ·Status: UNKNOWN ·Phase: PHASE3
-
Phase III Study of Neo-adjuvant Chemoradiotherapy Followed by Surgery for Squamous Cell Esophageal Cancer
NCT01216527 ·Status: UNKNOWN ·Phase: PHASE3
-
A Phase II Trial to Compare Efficacy and Safety of CRT VS Neo-CRT in Patients Who Achieved CCR for Esophageal Cancer
NCT02959385 ·Status: UNKNOWN ·Phase: PHASE2
-
IMRT With Carboplatin Versus IMRT With Carboplatin and Fluorouracil for Eldly Esophageal Cancer Patients
NCT03910634 ·Status: UNKNOWN ·Phase: PHASE2
-
Different Radiation Dose of Neoadjuvant Chemoradiation for Resectable Thoracic Esophageal Squamous Carcinoma
NCT03381651 ·Status: COMPLETED ·Phase: NA
-
Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies
NCT00921739 ·Status: COMPLETED ·Phase: PHASE1
-
Biomarkers and Functional Imaging in Predicting Response of Esophageal Cancer
NCT03029793 ·Status: UNKNOWN
-
High-dose Intensity Modulated Radiotherapy and Concurrent Chemotherapy in Esophageal Cancer
NCT03535207 ·Status: UNKNOWN ·Phase: NA
-
Definitive (Chemo)Radiotherapy for Patients With Esophageal Cancer - 3JECROG R-01
NCT03298204 ·Status: COMPLETED
-
Moderately Hypofractionated Conformal Radiation Combined With S-1 for Esophageal Squamous Cell Carcinoma
NCT03660449 ·Status: COMPLETED ·Phase: PHASE2
-
Comparing 61.2 Gy Radiotherapy Dose Versus 50.4 Gy Radiotherapy Dose for Locally Advanced Esophageal Carcinoma
NCT03790553 ·Status: UNKNOWN ·Phase: PHASE3
-
Neoadjuvant Radiochemotherapy Combined With Cadonilizumab for Local Advanced Esophageal Squamous Cell Cancer
NCT07016724 ·Status: RECRUITING ·Phase: PHASE2
-
Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patients
NCT03731442 ·Status: RECRUITING ·Phase: PHASE3
-
Report of the Survival Outcomes of Patients With Esophageal Cancer After Definitive Radiotherapy in China
NCT05194371 ·Status: COMPLETED
-
Patient-reported Outcomes in Preoperative Immunochemotherapy/Radiotherapy-treated Esophageal Cancer Patients
NCT05596890 ·Status: UNKNOWN ·Phase: PHASE2
-
Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma
NCT05937438 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Combination of Radiation Therapy and Peptide Specific CTL Therapy in Treating Patients With Esophageal Cancer
NCT03011255 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Extensive Clinical Target Volumes in Postoperative Radiotherapy Concurrent With Chemotherapy for Esophageal Squamous Cell Carcinoma
NCT02916511 ·Status: COMPLETED ·Phase: PHASE2
-
Chemoradiation Versus Esophagectomy for Locally Advanced Esophageal Cancer
NCT02972372 ·Status: RECRUITING ·Phase: NA
-
Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy
NCT06272214 ·Status: RECRUITING ·Phase: PHASE2